Cite

HARVARD Citation

    Peabody Lever, J. et al. (2020). Ataluren/ivacaftor combination therapy: Two N‐of‐1 trials in cystic fibrosis patients with nonsense mutations. Pediatric pulmonology. 55 (7), pp. 1838-1842. [Online]. 
  
Back to record